D.E. Shaw & Co
MD icon

D.E. Shaw & Co’s Pediatrix Medical MD Stock Holding History

D.E. Shaw & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-58,800
Closed -$2.69M – 4387
2013
Q2 		$2.69M Buy
+58,800
New +$2.63M 0.01% 1851

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

D.E. Shaw & Co's MD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Pediatrix Medical (MD) stake by 7.8% in Q1 2026, selling an estimated $2.99M and leaving 1,708,433 shares worth $36.5M. The position accounts for 0.02% of the portfolio, ranked #811.

D.E. Shaw & Co first reported a position in MD in Q2 2013 and has held it in 45 quarters since. The position peaked at $85.1M in Q4 2019. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • D.E. Shaw & Co held 1,708,433 shares of Pediatrix Medical worth $36.5M as of Q1 2026.
  • D.E. Shaw & Co sold 143,786 Pediatrix Medical shares in Q1 2026, an estimated $2.99M.
  • Pediatrix Medical made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #811 holding.
  • D.E. Shaw & Co first reported a position in Pediatrix Medical in Q2 2013 and has held it in 45 quarters since.
  • D.E. Shaw & Co's Pediatrix Medical position peaked at $85.1M in Q4 2019.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.